目次

1. Report Overview
1.1 Introduction to Biologics Market
1.2 Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Dynamics
3.1 Drivers
3.1.1 Advancements in Biomedical Science
3.1.2 Increasing Funding for the Development of Novel Biologic Drugs
3.1.3 Several Drugs Going Off Patents
3.2 Restraints
3.2.1 High Stringency and Low Turnover for Clinical Trials
3.2.2 Development of Biosimilars will Reduce the Demand for Biological Drugs
3.3 Opportunities
3.3.1 Biologic Therapies are Becoming Relevant in a Greater Number of Disease Areas
3.4 Challenges
3.4.1 Complexity in Development of Biologics
3.5 SWOT Analysis
3.5.1 Strengths
3.5.1.1 Rising Need for Effective biologics Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
3.5.2 Weaknesses
3.5.2.1 Financial Loss Due To Innovative Biologics Failure Has Been a Perennial Problem
3.5.3 Opportunities
3.5.3.1 Strong pipeline products and huge number of ongoing clinical trials are providing market growth opportunity.
3.5.3.2 Application of Nanotechnology in future
3.5.4 Threats
3.5.4.1 Small Molecules
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyers: Moderate
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis
3.7.1 Political Factors Impacting Biologics Market
3.7.2 Economic Factors Impacting Biologics Market
3.7.3 Social Factors Impacting Biologics Market
3.7.4 Technological Factors Impacting Biologics Market

4 Biologics Market by Product Type Forecast, 2022-2032
4.1 Monoclonal Antibodies Segment Market Forecast, 2022-2032
4.1.1 Monoclonal Antibodies: Holds Largest Market Share
4.1.2 Recovery Scenarios (V, U, W, L)
4.2 Vaccine Segment Market Forecast, 2022-2032
4.2.1 Vaccine Manufacturing Remains Concentrated, With Four Large Manufacturers
4.2.2 Recovery Scenarios (V, U, W, L)
4.3 Protein Therapeutics Segment Market Forecast, 2022-2032
4.3.1 Increased public knowledge of the benefits of protein therapies
4.3.2 Recovery Scenarios (V, U, W, L)
4.4 Regenerative Medicines Segment Market Forecast, 2022-2032
4.4.1 Government policies favouring Regenerative Medicines
4.4.2 Recovery Scenarios (V, U, W, L)
4.5 Fusion Proteins Segment Market Forecast, 2022-2032
4.5.1 Rising prevalence of diabetes expected to boost demand of fusion proteins
4.5.2 Recovery Scenarios (V, U, W, L)

5 Biologics Market by Application Forecast, 2022-2032
5.1 Oncology Segment Market Forecast, 2022-2032
5.1.1 Biological cancer therapy aims to train the immune system to recognise and kill cancer cells
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Autoimmune Diseases Segment Market Forecast, 2022-2032
5.2.1 Increasing Research and Development in this segment
5.2.2 Recovery Scenarios (V, U, W, L)
5.3 Infectious Diseases Therapeutics Segment Market Forecast, 2022-2032
5.3.1 Possible alternative to oral and parenteral routes of administration
5.3.2 Recovery Scenarios (V, U, W, L)
5.4 Cardiovascular Diseases Segment Market Forecast, 2022-2032
5.4.1 Cardiovascular Disorders is becoming the top cause of death worldwide
5.4.2 Recovery Scenarios (V, U, W, L)
5.5 Haematological Disorders Segment Market Forecast, 2022-2032
5.5.1 Blood disorders became a worldwide health issue
5.5.2 Recovery Scenarios (V, U, W, L)
5.6 Others Segment Market Forecast, 2022-2032
5.6.1 Adoption Haematological Disorders Technologies is expected to boost the Others Segment Growth
5.6.2 Recovery Scenarios (V, U, W, L)

6 Biologics Market by Manufacturing Forecast, 2022-2032
6.1 In-house Segment Market Forecast, 2022-2032
6.1.1 In-house holds largest Revenue market share
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Outsourced Segment Market Forecast, 2022-2032
6.2.1 Ease of use of Topical drug delivery to boost the outsourced market
6.2.2 Recovery Scenarios (V, U, W, L)

7 Global Biologics Market Forecast, 2022-2032
7.1 Global Biologics Market by Region Forecast 2022-2032
7.2 Recovery Scenarios (V, U, W, L)

8 North America Biologics Market, 2022-2032
8.1 Largest share acquired by North America in Global Biologics Market
8.2 North America Biologics Market by Country, Forecast 2022-2032
8.3 North America Biologics Market Forecast by Product Type
8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2022-2032
8.4 North America Biologics Market Forecast by Application
8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2022-2032
8.5 North America Biologics Market Forecast by Manufacturing
8.5.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2022-2032
8.6 U.S. Biologics Market Forecast, 2022-2032
8.6.1 Growing public and private funding for research studies in this region
8.6.2 Budget request for Pandemic preparedness
8.6.3 Recovery Scenarios (V, U, W, L): U.S. Biologics Market Forecast, 2022-2032
8.7 Canada Biologics Market Forecast, 2022-2032
8.7.1 Growing Prevalence of Psoriasis and Related Research and Development across the Region
8.7.2 Biologics represent a large segment of drug spending in Canada
8.7.3 Recovery Scenarios (V, U, W, L): Canada Biologics Market Forecast, 2022-2032

9 Europe Biologics Market, 2022-2032
9.1 Launch of Advanced Biologics across the Region
9.2 Europe Biologics Market by Country, Forecast 2022-2032
9.3 Europe Biologics Market Forecast by Product Type
9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Product Type, 2022-2032
9.4 Europe Biologics Market Forecast by Application
9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2022-2032
9.5 Europe Biologics Market Forecast by Manufacturing
9.5.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2022-2032
9.6 Germany Biologics Market Forecast, 2022-2032
9.6.1 German government support market player for product development
9.6.2 Recovery Scenarios (V, U, W, L): Germany Biologics Market Forecast, 2022-2032
9.7 U.K. Biologics Market Forecast, 2022-2032
9.7.1 Increase in prevalence of diabetes and skin conditions
9.7.2 Recovery Scenarios (V, U, W, L): U.K. Biologics Market Forecast, 2022-2032
9.8 France Biologics Market Forecast, 2022-2032
9.8.1 Growing cancer prevalence and French government cancer control strategy
9.8.2 Recovery Scenarios (V, U, W, L): France Biologics Market Forecast, 2022-2032
9.9 Italy Biologics Market Forecast, 2022-2032
9.9.1 Rising prevalence of cancer
9.9.2 Recovery Scenarios (V, U, W, L): Italy Biologics Market Forecast, 2022-2032
9.10 Spain Biologics Market Forecast, 2022-2032
9.10.1 Growing burden of Infectious diseases
9.10.2 Recovery Scenarios (V, U, W, L): Spain Biologics Market Forecast, 2022-2032
9.11 Russia Biologics Market Forecast, 2022-2032
9.11.1 Major leap forward in terms of Digitalization
9.11.2 Recovery Scenarios (V, U, W, L): Russia Biologics Market Forecast, 2022-2032
9.12 Rest of Europe Biologics Market Forecast, 2022-2032
9.12.1 Rising Adoption of Advanced Biologics
9.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Biologics Market Forecast, 2022-2032

10 Asia Pacific Biologics Market, 2022-2032
10.1 Biologics APAC will emerge as the fastest growing regional market for biologics market R&D and production
10.2 Asia Pacific Biologics Market by Country, Forecast 2022-2032
10.3 Asia Pacific Biologics Market Forecast by Product Type
10.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Product Type, 2022-2032
10.4 Asia Pacific Biologics Market Forecast by Application
10.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Application, 2022-2032
10.5 Asia Pacific Biologics Market Forecast by Manufacturing
10.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032
10.6 Japan Biologics Market Forecast, 2022-2032
10.6.1 Major market players investing on R&D
10.6.2 Recovery Scenarios (V, U, W, L): Japan Biologics Market Forecast, 2022-2032
10.7 China Biologics Market Forecast, 2022-2032
10.7.1 Rapid growth of Domestic mAb pipeline and regulatory reform is creating business opportunities for Biologics CDMO’s in China
10.7.2 Recovery Scenarios (V, U, W, L): China Biologics Market Forecast, 2022-2032
10.8 India Biologics Market Forecast, 2022-2032
10.8.1 India Biologics market currently is dominated by Simple Biologics
10.8.2 Recovery Scenarios (V, U, W, L): India Biologics Market Forecast, 2022-2032
10.9 Australia Biologics Market Forecast, 2022-2032
10.9.1 Growing capital investment by the market player
10.9.2 Recovery Scenarios (V, U, W, L): Australia Biologics Market Forecast, 2022-2032
10.10 South Korea Biologics Market Forecast, 2022-2032
10.10.1 Increasing prevalence of Cancer in South Korea
10.10.2 Recovery Scenarios (V, U, W, L): South Korea Biologics Market Forecast, 2022-2032
10.11 Rest of Asia Pacific Biologics Market Forecast, 2022-2032
10.11.1 Rising Disposable Income in this region
10.11.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biologics Market Forecast, 2022-2032

11 Latin America Biologics Market, 2022-2032
11.1 Latin America Biologics Market expected to grow at lucrative CAGR
11.2 Latin America Biologics Market by Country, Forecast 2022-2032
11.3 Latin America Biologics Market Forecast by Product Type
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2022-2032
11.4 Latin America Biologics Market Forecast by Application
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2022-2032
11.5 Latin America Biologics Market Forecast by Manufacturing
11.5.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2022-2032
11.6 Brazil Biologics Market Forecast, 2022-2032
11.6.1 High Potential Manufacturing Environment
11.6.2 Recovery Scenarios (V, U, W, L): Brazil Biologics Market Forecast, 2022-2032
11.7 Mexico Biologics Market Forecast, 2022-2032
11.7.1 Lower Manufacturing Cost in Mexico
11.7.2 Recovery Scenarios (V, U, W, L): Mexico Biologics Market Forecast, 2022-2032
11.8 Rest of Latin America Biologics Market Forecast, 2022-2032
11.8.1 Developing Healthcare Infrastructure in this region
11.8.2 Recovery Scenarios (V, U, W, L): Rest of Latin America Biologics Market Forecast, 2022-2032

12 MEA Biologics Market, 2022-2032
12.1 Increasing occurrence of Cancer in this region
12.2 MEA Biologics Market by Country, Forecast 2022-2032
12.3 MEA Biologics Market Forecast by Product Type
12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Product Type, 2022-2032
12.4 MEA Biologics Market Forecast by Application
12.4.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2022-2032
12.5 MEA Biologics Market Forecast by Manufacturing
12.5.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Manufacturing, 2022-2032
12.6 GCC Biologics Market Forecast, 2022-2032
12.6.1 Presence of Hug Growth Opportunities
12.6.2 Recovery Scenarios (V, U, W, L): GCC Biologics Market Forecast, 2022-2032
12.7 South Africa Biologics Market Forecast, 2022-2032
12.7.1 Rapidly increasing infectious diseases in this South Africa
12.7.2 Recovery Scenarios (V, U, W, L): South Africa Biologics Market Forecast, 2022-2032
12.8 Rest of MEA Biologics Market Forecast, 2022-2032
12.8.1 Cancer is one of the main reason of Death causes in Rest of MEA
12.8.2 Recovery Scenarios (V, U, W, L): Rest of MEA Biologics Market Forecast, 2022-2032

13 Company Profiles
13.1 Company Share Analysis
13.2 Biologics Market Recent Developments
13.3 Johnson & Johnson Services, Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Revenue/Market Shares, 2021
13.3.3.3 Segmental Revenue/Market Shares, 2021
13.3.4 Product Benchmarking
13.3.5 Recent Developments
13.4 Merck KGaA
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Revenue/Market Shares, 2021
13.4.3.3 Segmental Revenue/Market Shares, 2021
13.4.4 Product Benchmarking
13.4.5 Recent Developments
13.5 GlaxoSmithKline plc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.3.2 Regional Revenue/Market Shares, 2021
13.5.3.3 Segmental Revenue/Market Shares, 2021
13.5.4 Product Benchmarking
13.5.5 Recent Developments
13.6 Novartis AG
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2021
13.6.3.2 Regional Revenue/Market Shares, 2021
13.6.3.3 Segmental Revenue/Market Shares, 2021
13.6.4 Product Benchmarking
13.6.5 Recent Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Segmental Revenue/Market Shares, 2021
13.7.3.3 Regional Revenue/Market Shares, 2020
13.7.4 Product Benchmarking
13.7.5 Recent Developments
13.8 Pfizer Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.3.2 Regional Revenue/Market Shares, 2021
13.8.3.3 Segmental Revenue/Market Shares, 2021
13.8.4 Product Benchmarking
13.8.5 Recent Developments
13.9 Sanofi
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Revenue/Market Shares, 2021
13.9.3.3 Segmental Revenue/Market Shares, 2021
13.9.4 Product Benchmarking
13.9.5 Recent Developments
13.10 Novo Holdings A/S (Novo Nordisk A/S)
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2021
13.10.3.2 Regional Revenue/Market Shares, 2020
13.10.3.3 Segmental Revenue/Market Shares, 2020
13.10.4 Product Benchmarking
13.10.5 Recent Developments
13.11 Takeda Pharmaceutical Company Limited
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2021
13.11.3.2 Regional Revenue/Market Shares, 2020
13.11.3.3 Segmental Revenue/Market Shares, 2020
13.11.4 Product Benchmarking
13.12 Eli Lilly and Company
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.3.2 Regional Revenue/Market Shares, 2020
13.12.4 Product Benchmarking
13.12.5 Recent Developments
13.13 Amgen Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 Regional Revenue Shares, 2021
13.13.3.3 Segment Revenue Shares, 2021
13.13.4 Product Benchmarking
13.13.5 Recent Developments
13.14 Bristol-Myers Squibb Company
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Regional Revenue Shares, 2021
13.14.4 Product Benchmarking
13.14.5 Recent Developments
13.15 Biogen
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Regional Revenue Shares, 2021
13.15.4 Product Benchmarking
13.15.5 Recent Developments
13.16 NuVasive, Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.3.2 Regional Revenue Shares, 2021
13.16.3.3 Segment Revenue Shares, 2021
13.16.4 Product Benchmarking
13.17 ORTHOFIX INTERNATIONAL N.V.
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Regional Revenue Shares, 2021
13.17.3.3 Segment Revenue Shares, 2020
13.17.4 Product Benchmarking
13.18 Organogenesis Holdings Inc.
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Financial Analysis
13.18.3.1 Net Revenue, 2018-2021
13.18.3.2 Segment Revenue Shares, 2021
13.18.4 Product Benchmarking
13.19 AbbVie Inc.
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.3.1 Net Revenue, 2017-2021
13.19.3.2 Regional Revenue Shares, 2021
13.19.3.3 Segment Revenue Shares, 2021
13.19.4 Product Benchmarking
13.19.5 Recent Developments

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 Global Biologics Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 3 Global Biologics examples of US FDA-approved monoclonal antibody present in the market, CAGR%)
Table 4 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 5 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 20 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 25 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 30 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Biologics Market for Autoimmune diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 46 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 56 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 1 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 60 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 61 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 66 Global Biologics Market for outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 North America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 76 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 82 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 87 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 97 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 102 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 103 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 104 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 105 Europe Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 106 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 108 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 113 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 114 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 115 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 116 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 117 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 118 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 123 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 128 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 133 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 138 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 143 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 148 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Asia Pacific Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 154 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 159 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 164 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 169 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 172 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 173 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 174 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 177 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 178 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 179 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 182 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 183 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 184 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 187 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 188 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 189 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 194 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Latin America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 199 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 200 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 205 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 210 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 215 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 216 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 217 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 218 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 220 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 225 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 226 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 227 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 228 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 229 MEA Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 230 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 231 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 232 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 233 MEA Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 234 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 235 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 236 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 237 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 238 MEA Biologics Market Forecast by application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 239 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 240 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 241 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 242 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 243 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 244 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 245 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 246 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 247 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 248 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 249 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 250 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 251 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 252 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 253 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 254 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 256 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 260 Biologics Market Company Ranking for the Year 2021
Table 261 Biologics Market Recent Developments
Table 262 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Johnson & Johnson Services Inc.: Product Benchmarking
Table 264 Johnson & Johnson Services inc.: Recent Developments
Table 265 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 Merck KGaA: Product Benchmarking
Table 267 Merck KGaA: Recent Developments
Table 268 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 GlaxoSmithKline plc.: Product Benchmarking
Table 270 GlaxoSmithKline plc.: Recent Developments
Table 271 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 272 Novartis AG: Product Benchmarking
Table 273 Novartis AG: Recent Developments
Table 274 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 275 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 276 F. Hoffmann-La Roche Ltd: Recent Developments
Table 277 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 278 Pfizer Inc.: Product Benchmarking
Table 279 Pfizer Inc.: Recent Developments
Table 280 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 281 Sanofi: Product Benchmarking
Table 282 Sanofi: Recent Developments
Table 283 Novo Holdings A/S (Novo Nordisk A/S): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 284 Novo Holdings A/S (Novo Nordisk A/S): Product Benchmarking
Table 285 Novo Holdings A/S (Novo Nordisk A/S): Recent Developments
Table 286 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 287 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 288 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Eli Lilly and Company: Product Benchmarking
Table 290 Eli Lilly and Company: Recent Developments
Table 291 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Amgen Inc.: Product Benchmarking
Table 293 Amgen Inc.: Recent Developments
Table 294 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Bristol-Myers Squibb Company: Product Benchmarking
Table 296 Bristol-Myers Squibb Company: Recent Developments
Table 297 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Biogen: Product Benchmarking
Table 299 Biogen: Recent Developments
Table 300 NuVasive, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 301 NuVasive, Inc.: Product Benchmarking
Table 302 ORTHOFIX INTERNATIONAL N. V. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 ORTHOFIX INTERNATIONAL N.V. : Product Benchmarking
Table 304 Organogenesis Holdings Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 Organogenesis Holdings Inc. : Product Benchmarking
Table 306 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 307 AbbVie Inc.: Product Benchmarking
Table 308 AbbVie Inc. : Recent Developments

List of Figures
Figure 1 Global Biologics Market Segmentation
Figure 2 Global Biologics Market: Market Dynamics
Figure 3 Global Biologics Market: SWOT Analysis
Figure 4 Global Biologics Market: Porter’s Five Forces Analysis
Figure 5 Global Biologics Market: PEST Analysis
Figure 6 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 7 Global Biologics Market Share Forecast by Product Type, 2022, 2026, 2032 (%)
Figure 8 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 9 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Biologics Market for Vaccine Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 14 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 19 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 24 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 29 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR %)
Figure 34 Global Biologics Market Share Forecast by Application, 2022, 2026, 2032 (%)
Figure 35 Global Biologics Market for Oncology Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 36 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 37 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 38 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 39 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 40 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 41 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 46 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Biologics Market for Cardiovascular Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 51 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Biologics Market for Haematological Disorders Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 56 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Biologics Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 61 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 62 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 63 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 64 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 65 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 66 Global Biologics Market Share Forecast by Manufacturing, 2022, 2026, 2032 (%)
Figure 67 Global Biologics Market for In-house Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 68 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 69 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 70 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 71 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 72 Global Biologics Market for Outsourced Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 73 Global Biologics Market for Outsourced Segment, Revenue Fore